Adverum Biotechnologies Inc. is a clinical-stage gene therapy company focused on developing treatments for ocular diseases. Utilizing their proprietary platform, they aim to provide long-lasting solutions for patients with currently unmet medical needs. With a promising pipeline and strategic collaborations, Adverum has the potential to revolutionize the field of gene therapy.
Notification